PDCD1 and neoplasm: One major limitation is that while PD-1 and other immune indicators have been found to be more highly expressed in tumor infiltration compared to circulating T cells [40], it is challenging to measure the level of PD-L1 expression in tumor tissue during definitive radiotherapy.